GlassScriptPhysician profile
Joseph M Abboud
NPI 1295757649
$42,187.92
in general payments reported to CMS, 2019-2025
61 companies · $2,912 in 2025
The $2,912 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,784 · 2020: $1,070 · 2021: $1,106 · 2022: $2,136 · 2023: $3,345 · 2024: $29K · 2025: $2,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $25K · Food and Beverage: $9,605 · Travel and Lodging: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $25,090.38 |
| Food and Beverage | $9,604.61 |
| Travel and Lodging | $397.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $25,491.21 | 2019-2024 | Iconix, Tornier Perform Reversed Augmented Glenoid |
| Astrazeneca Pharmaceuticals LP | $2,601.78 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $1,833.53 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,177.83 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Insmed, INC. | $790.23 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $593.68 | 2022-2024 | |
| Mylan Specialty L.P. | $567.82 | 2019-2024 | Yupelri |
| Harmony Biosciences LLC | $520.78 | 2020-2025 | Wakix |
| Zimmer Biomet Holdings, INC. | $507.09 | 2023-2024 | Comprehensive Shoulder System, Tricera Handpiece |
| Boston Scientific Corporation | $452.32 | 2019-2025 | Watchman Flx, Farapulse |
| Regeneron Healthcare Solutions, INC. | $449.26 | 2022-2025 | Dupixent |
| Encore Medical, LP | $445.70 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $440.84 | 2019-2025 | Opsumit, Uptravi |
| United Therapeutics Corporation | $369.59 | 2024-2025 | Tyvaso, Tyvaso |
| Genentech USA, INC. | $324.12 | 2019-2024 | Xolair |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $309.61 | 2019-2025 | Remede System |
| Inspire Medical Systems, INC. | $300.20 | 2023-2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $299.73 | 2020-2025 | Aralast |
| Philips North America LLC | $293.64 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Grifols USA, LLC | $287.01 | 2020-2025 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $267.48 | 2023-2025 | Sunosi |
| Alexion Pharmaceuticals, INC. | $266.63 | 2019-2025 | Ultomiris |
| Janssen Pharmaceuticals, INC | $264.92 | 2019-2023 | Xarelto |
| Amgen INC. | $246.62 | 2023-2025 | Tezspire, Tavneos |
| Janssen Scientific Affairs, LLC | $237.76 | 2019-2020 | |
| Abbvie INC. | $216.16 | 2022-2025 | Avycaz |
| Pulmonx Corporation | $215.23 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Mallinckrodt Hospital Products INC. | $169.32 | 2020-2025 | Acthar |
| Viatris Specialty LLC | $153.26 | 2025 | Yupelri |
| Verona Pharma, INC. | $142.68 | 2025 | Ohtuvayre |
| Paratek Pharmaceuticals, INC. | $141.13 | 2020-2021 | |
| Avadel Cns Pharmaceuticals, LLC | $136.75 | 2024-2025 | Lumryz |
| E.R. Squibb & Sons, L.L.C. | $130.71 | 2022-2024 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $123.97 | 2019 | |
| Impulse Dynamics (USA) INC. | $122.62 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $119.78 | 2019 | |
| Ani Pharmaceuticals, INC. | $106.48 | 2023 | Purified Cortrophin Gel |
| Merck Sharp & Dohme LLC | $93.38 | 2022-2024 | Recarbrio, Zerbaxa |
| Sunovion Pharmaceuticals INC. | $84.63 | 2019 | |
| Tactile Systems Technology INC | $81.92 | 2024 | Entre Plus, Flexitouch Plus |
| Jazz Pharmaceuticals INC. | $80.81 | 2019-2023 | |
| Baxter Healthcare | $77.91 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Pfizer INC. | $59.22 | 2022-2025 | |
| Electromed, INC. | $53.92 | 2023-2024 | Smartvest |
| Globus Medical, INC. | $53.78 | 2019 | |
| Nestle Healthcare Nutrition INC. | $50.04 | 2022 | |
| Mallinckrodt Enterprises LLC | $47.95 | 2019 | |
| Shionogi INC | $45.03 | 2025 | Fetroja |
| Resmed Corp | $42.77 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.34 | 2022-2024 | |
| Optinose US, INC. | $38.39 | 2025 | |
| Portola Pharmaceuticals, LLC | $29.28 | 2020 | |
| Allergan, INC. | $29.17 | 2019-2020 | |
| Phadia US INC. | $27.38 | 2019 | |
| Inogen, INC. | $26.96 | 2023 | Inogen One G3 Oxygen Concentrator |
| La Jolla Pharmaceutical Company | $24.24 | 2024 | Giapreza |
| Idorsia Pharmaceuticals US INC | $22.30 | 2023 | Quviviq |
| Vifor Pharma, INC. | $18.34 | 2025 | Veltassa |
| Astellas Pharma US INC | $15.00 | 2024 | Cresemba |
| Nabriva Therapeutics, Plc | $13.98 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Abboud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.